SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DRSLTR - Correspondence Related to Draft Registration Statement:
SEC Accession No. 0000950123-22-009779
Filing Date
2022-09-02
Accepted
2022-09-02 17:28:47
Documents
3

Document Format Files

Seq Description Document Type Size
1 filename1.htm DRSLTR 21203
2 GRAPHIC g241143g22i68.jpg GRAPHIC 3056
3 GRAPHIC g241143g72n13.jpg GRAPHIC 2246
  Complete submission text file 0000950123-22-009779.txt   29792
Mailing Address 490 ARSENAL WAY, SUITE 200 WATERTOWN MA 02472
Business Address 490 ARSENAL WAY, SUITE 200 WATERTOWN MA 02472 (857) 760-0900
Neumora Therapeutics, Inc. (Filer) CIK: 0001885522 (see all company filings)

IRS No.: 844367680 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DRSLTR
SIC: 2836 Biological Products, (No Diagnostic Substances)